Adaptogenics Health Corp. Proposes Private Placement to Fund Growth Initiatives

Vancouver, British Columbia — November 16, 2026 — Leads & Copy — Adaptogenics Health Corp. announced its intention to conduct a non-brokered private placement aimed at raising up to $625,000 through the issuance of up to 2,500,000 units at $0.25 per unit. Each unit will comprise one common share and a half of a common share purchase warrant. These warrants will allow holders to purchase an additional common share at $0.75 for 24 months following issuance.

The company plans to allocate the net proceeds from this offering to its e-commerce operations, nutritional products, peptide sourcing, and research and development initiatives. Additional funds will be designated for personnel, investor relations, and general working capital.

The private placement is anticipated to close in multiple tranches and is contingent upon regulatory approvals, including acceptance from the Canadian Securities Exchange. Securities issued under this offering will be subject to a statutory hold period of four months and one day after their issuance, in accordance with securities laws.

Adaptogenics Health Corp. may also issue common shares to eligible finders who introduce subscribers to the offering. The number of shares issued to finders will be equivalent to 7% of the units sold to subscribers they introduced, subject to securities laws and exchange policies.

The securities offered have not been registered under the United States Securities Act of 1933 and may not be sold in the U.S. or to U.S. persons without registration or an applicable exemption. The press release does not constitute an offer to sell or a solicitation to buy securities in any jurisdiction where such activity would be unlawful.

Adaptogenics Health Corp. is pursuing a strategy focused on proprietary peptide and small molecule opportunities within metabolic health, muscle preservation, mitochondrial biology, and inflammation. The company is also exploring GLP-1 companion products through its existing health products business, designed to support nutritional health and muscle function for individuals undergoing medically induced weight loss.

Source: Adaptogenics Health Corp.